Concepedia

David Kayne

DK

Statistics

Publications

5

Citations

838

H-Index

5

Active since

2000

Affiliations

University at Buffalo, State University of New York(Current)

David Kayne is an author at University at Buffalo, State University of New York specializing in metabolic syndrome, diabetes, and medicine.

Top concepts

Publications per year

2000–2022

5

Publications

5

Performance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home Use

Todd M. Gross, Bruce W. Bode, Daniel Einhorn et al. · Diabetes Technology & Therapeutics · 2000 · 301 citations

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 286 citations · Full text

, , +9

A Bolus Calculator Is an Effective Means of Controlling Postprandial Glycemia in Patients on Insulin Pump Therapy

Todd M. Gross, David Kayne, Allen B. King et al. · Diabetes Technology & Therapeutics · 2003 · 143 citations

, , +15

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

Erin A. Bohula, Benjamin M. Scirica, Silvio E. Inzucchi et al. · The Lancet · 2018 · 94 citations · Full text

, , +9

Treatment persistence and adherence in people with type 2 diabetes switching to iGlarLixi vs free-dose combinations of basal insulin and glucagon-like peptide 1 receptor agonist

Steven V. Edelman, Doreen Cassarino, David Kayne et al. · Journal of Managed Care & Specialty Pharmacy · 2022 · 14 citations · Full text

1–5 of 5